Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy
2010
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Cardiovascular prevention and blood pressure reduction
2003
Long-term outcome of Peripartum cardiomyopathy in a population with high seropositivity for Human Immunodeficiency Virus
2009
Peripartum cardiomyopathy—a new treatment option by inhibition of prolactin secretion
2008
Peripartum cardiomyopathy: a condition intensivists should be aware of
2003
Peripartum cardiomyopathy
2006
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Role of Tumour Necrosis Factor-?? in the Progression of Heart Failure
2000
Prospects for Cardiovascular Research
2001 StandoutNobel
Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa
2007
ECM remodeling in hypertensive heart disease
2007
Cushing's syndrome
2015 Standout
Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis
2007
Crosslink breakers: a new approach to cardiovascular therapy
2004
The burden of non-communicable diseases in South Africa
2009 Standout
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Impact of pregnancy-related heart failure on humoral immunity: Clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy
2005
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
2005
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Unrecognized peripartum cardiomyopathy in Haitian women
2005
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure
2005
Peripartum Cardiomyopathy
2005
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
The development of allergic inflammation
2008 StandoutNature
Cardiovascular complications in diabetes mellitus
2005
Peripartum cardiomyopathy
2009
Toward a Causal Model of Cardiovascular Responses to Stress and the Development of Cardiovascular Disease
2003
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling
2011
The role of tumor necrosis factor in the pathophysiology of heart failure
2000
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy
2005
Emergency Department Evaluation and Management of Peripartum Cardiomyopathy
2007
Constructive and unconstructive repetitive thought.
2008 Standout
Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure
2007
Sex differences in immune responses
2016 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Peripartum cardiomyopathy
2005
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
2000
Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
2010
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Peripartum Cardiomyopathy
2008
Biomarkers in Heart Failure
2008 Standout
Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients
2005
The ABC transporter structure and mechanism: perspectives on recent research
2004
The Role of Anti-Cytokine Therapy in the Failing Heart
2001
Adipose Tissue as an Endocrine Organ
2004 Standout
Tumour Necrosis Factor in Chronic Heart Failure
2000
Frequency of Peripartum Cardiomyopathy
2006
Myocarditis
2009 Standout
Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
2014
Systematic review of pregnancy in women with inherited cardiomyopathies
2011
An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
2000
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
2010 Standout
Reversal of IFN‐γ, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy
2008
The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men
2004
Myocarditis
2006 Standout
Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients. Results of the Baragwanath trial
2002
Collagen gene expression in rat left ventricle: interactive effect of age and exercise training
2000
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive Rats
2004
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
2003 Standout
Weight Loss and the Renin-Angiotensin-Aldosterone System
2005
Advanced Glycation End Products
2006 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes
2003
Pharmacogenetics and asthma: false hope or new dawn?: Table 1—
2007
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Oxidative Stress and Diabetic Complications
2010 Standout
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure
2001
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008
Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart Failure
1999
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Mechanisms of Diabetic Complications
2013 Standout
Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy
1998
Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist
2003
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Reviewing Peripartum Cardiomyopathy: Current State of Knowledge
2009
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Inflammatory Markers and Onset of Cardiovascular Events
2003 Standout
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
2004
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure
2001
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
2003 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys
2001
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Reduction in Myocardial Collagen Cross-Linking Parallels Left Ventricular Dilatation in Rat Models of Systolic Chamber Dysfunction
2001
Physiology of Microglia
2011 Standout
Pregnancy-Associated Cardiomyopathy
2005
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Geoffrey Candy being referenced
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy
2002
Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy
1998
Association analysis of β2 adrenoceptor polymorphisms with hypertension in a Black African population
2000
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1
2000
Efficacy of Different Drug Classes Used to Initiate Antihypertensive Treatment in Black Subjects
2001
Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy
2004
Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure
2004
The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy
2002
Therapy of Ischemic Cardiomyopathy With the Immunomodulating Agent Pentoxifylline
2004
Aminoguanidine Prevents the Decreased Myocardial Compliance Produced by Streptozotocin-Induced Diabetes Mellitus in Rats
1996
Angiotensinogen Gene Promoter Region Variant Modifies Body Size–Ambulatory Blood Pressure Relations in Hypertension
2002
Myocardial Stiffness Is Attributed to Alterations in Cross-Linked Collagen Rather Than Total Collagen or Phenotypes in Spontaneously Hypertensive Rats
1997
Antihypertensive Effect of Low‐Dose Hydrochlorothiazide Alone or in Combination with Quinapril in Black Patients with Mild to Moderate Hypertension
2000
Beneficial Effects of Pentoxifylline in Patients With Idiopathic Dilated Cardiomyopathy Treated With Angiotensin-Converting Enzyme Inhibitors and Carvedilol
2001
Relationship Between Treatment-Induced Changes in Left Ventricular Mass and Blood Pressure in Black African Hypertensive Patients
2002
Cryptococcal pneumonia in African miners at autopsy.
2007